Mesenchymal stem cells and their potential for clinical use

W. Noort (Amsterdam, The Netherlands)

Source: Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung
Session: Cellular and molecular strategies to repair the damaged lung
Session type: Major Symposium
Number: 128

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Noort (Amsterdam, The Netherlands). Mesenchymal stem cells and their potential for clinical use. Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mesenchymal stem cells in aging and IPF
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016


Embryonic stem cells as source for endothelial cells for cell-based therapies
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009



Mesenchymal stromal cells in clinical trials: implications for emphysema
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017


Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021


Mesenchymal stem cell therapy for severe emphysema
Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer
Year: 2021


Mesenchymal stem cell therapy for severe emphysema
Source: ERS Lung Science Conference 2021
Year: 2021



Mesenchymal stem cells and fibrotic lung diseases
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014



Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Mesenchymal stem cells and recombinant erythropoietin treatment in an experimental sepsis model
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012

Mesenchymal stromal cells and macrophages in sepsis: new insights
Source: Eur Respir J, 51 (4) 1800510; 10.1183/13993003.00510-2018
Year: 2018



YI05 - Mesenchymal stromal cells identified in tissue from lung-transplanted patients
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012

Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021